Vanguard Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $216M | Buy |
13,057,890
+1,064,972
| +9% | +$18M | ﹤0.01% | 1514 |
|
|
2025
Q3 | $174M | Buy |
11,992,918
+182,183
| +2% | +$2.62M | ﹤0.01% | 1607 |
|
|
2025
Q2 | $165M | Buy |
11,810,735
+10,978
| +0.1% | +$155K | ﹤0.01% | 1600 |
|
|
2025
Q1 | $160M | Sell |
11,799,757
-221,473
| -2% | -$4.24M | ﹤0.01% | 1575 |
|
|
2024
Q4 | $245M | Buy |
12,021,230
+843,996
| +8% | +$21.6M | ﹤0.01% | 1449 |
|
|
2024
Q3 | $326M | Sell |
11,177,234
-135,205
| -1% | -$3.35M | 0.01% | 1283 |
|
|
2024
Q2 | $263M | Buy |
11,312,439
+344,146
| +3% | +$6.61M | 0.01% | 1344 |
|
|
2024
Q1 | $225M | Buy |
10,968,293
+133,810
| +1% | +$2.51M | ﹤0.01% | 1443 |
|
|
2023
Q4 | $233M | Buy |
10,834,483
+236,702
| +2% | +$4.69M | 0.01% | 1419 |
|
|
2023
Q3 | $219M | Buy |
10,597,781
+354,798
| +3% | +$9M | 0.01% | 1393 |
|
|
2023
Q2 | $302M | Buy |
10,242,983
+124,490
| +1% | +$3.5M | 0.01% | 1238 |
|
|
2023
Q1 | $233M | Buy |
10,118,493
+171,395
| +2% | +$4.72M | 0.01% | 1372 |
|
|
2022
Q4 | $277M | Buy |
9,947,098
+1,545,067
| +18% | +$46M | 0.01% | 1241 |
|
|
2022
Q3 | $258M | Buy |
8,402,031
+99,530
| +1% | +$3.24M | 0.01% | 1237 |
|
|
2022
Q2 | $244M | Buy |
8,302,501
+190,471
| +2% | +$4.99M | 0.01% | 1306 |
|
|
2022
Q1 | $261M | Sell |
8,112,030
-49,500
| -0.6% | -$1.7M | 0.01% | 1374 |
|
|
2021
Q4 | $364M | Sell |
8,161,530
-6,953
| -0.1% | -$329K | 0.01% | 1204 |
|
|
2021
Q3 | $412M | Buy |
8,168,483
+524,353
| +7% | +$29.6M | 0.01% | 1100 |
|
|
2021
Q2 | $600M | Sell |
7,644,130
-522,320
| -6% | -$32.3M | 0.01% | 881 |
|
|
2021
Q1 | $466M | Buy |
8,166,450
+241,393
| +3% | +$16.2M | 0.01% | 990 |
|
|
2020
Q4 | $664M | Buy |
7,925,057
+1,223,317
| +18% | +$74M | 0.02% | 745 |
|
|
2020
Q3 | $240M | Sell |
6,701,740
-384,190
| -5% | -$11.6M | 0.01% | 1164 |
|
|
2020
Q2 | $171M | Buy |
7,085,930
+177,599
| +3% | +$4.18M | 0.01% | 1370 |
|
|
2020
Q1 | $121M | Buy |
6,908,331
+700,789
| +11% | +$14.6M | 0.01% | 1418 |
|
|
2019
Q4 | $108M | Buy |
6,207,542
+110,096
| +2% | +$1.83M | ﹤0.01% | 1707 |
|
|
2019
Q3 | $93.4M | Buy |
6,097,446
+286,131
| +5% | +$5.47M | ﹤0.01% | 1765 |
|
|
2019
Q2 | $121M | Sell |
5,811,315
-771,534
| -12% | -$17.3M | ﹤0.01% | 1649 |
|
|
2019
Q1 | $153M | Buy |
6,582,849
+27,966
| +0.4% | +$585K | 0.01% | 1514 |
|
|
2018
Q4 | $135M | Buy |
6,554,883
+1,727,173
| +36% | +$31.3M | 0.01% | 1491 |
|
|
2018
Q3 | $105M | Buy |
4,827,710
+1,660,984
| +52% | +$27.5M | ﹤0.01% | 1778 |
|
|
2018
Q2 | $48.3M | Buy |
3,166,726
+2,033,787
| +180% | +$38.3M | ﹤0.01% | 2153 |
|
|
2018
Q1 | $22.3M | Buy |
1,132,939
+206,223
| +22% | +$4.24M | ﹤0.01% | 2457 |
|
|
2017
Q4 | $14.5M | Buy |
+926,716
| New | +$16.7M | ﹤0.01% | 2650 |
|
Other funds holding DNLI
